Resources
Materials available as editable pdfs:
Medicinal Name | Material | Description | Download |
---|---|---|---|
Lenalidomide | Healthcare Professional’s Pack | Contains the complete information needed by healthcare professionals for prescribing and dispensing Accord Lenalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient. The pack contains all educational risk minimisation materials | Download PDF |
Thalidomide | Healthcare Professional’s Pack | Contains the complete information needed by healthcare professionals for prescribing and dispensing Accord Thalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient. The pack contains all educational risk minimisation materials | Download PDF |
Lenalidomide | Pharmacy Registration Form (PRF) | Form for completion by the Chief Pharmacist, or their Appointed Deputy. Only pharmacies registered with Accord via the PRF can order and dispense Accord Lenalidomide | Download PDF |
Thalidomide | Pharmacy Registration Form (PRF) | Form for completion by the Chief Pharmacist, or their Appointed Deputy. Only pharmacies registered with Accord via the PRF can order and dispense Accord Thalidomide | Download PDF |
Lenalidomide | Prescription Authorisation Form (PAF) | Form for completion by the prescriber and pharmacist. Each prescription of Accord Lenalidomide must be accompanied by a newly completed Prescription Authorisation Form (PAF) | Download PDF |
Thalidomide | Prescription Authorisation Form (PAF) | Form for completion by the prescriber and pharmacist. Each prescription of Accord Thalidomide must be accompanied by a newly completed Prescription Authorisation Form (PAF) | Download PDF |
Lenalidomide | Male Treatment Initiation Form (TIF) | Form for completion by the prescriber for each male patient prior to the initiation of their Lenalidomide treatment. It is mandatory that all males receive counselling and education to be made aware of the risks with this medicine | Download PDF |
Thalidomide | Male Treatment Initiation Form (TIF) | Form for completion by the prescriber for each male patient prior to the initiation of their Thalidomide treatment. It is mandatory that all males receive counselling and education to be made aware of the risks with this medicine | Download PDF |
Lenalidomide | Women of Childbearing Potential (WCBP) Treatment Initiation Form (TIF) | Form for completion by the prescriber for each woman of childbearing potential prior to the initiation of their Lenalidomide treatment. It is mandatory that women of childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
Thalidomide | Women of Childbearing Potential (WCBP) Treatment Initiation Form (TIF) | Form for completion by the prescriber for each woman of childbearing potential prior to the initiation of their Thalidomide treatment. It is mandatory that women of childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
Lenalidomide | Women of Non-childbearing Potential (WNCBP) Treatment Initiation Form (TIF) | Form for completion by the prescriber for each woman of non-childbearing potential prior to the initiation of their Lenalidomide treatment. It is mandatory that women of non-childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
Thalidomide | Women of Non-childbearing Potential (WNCBP) Treatment Initiation Form (TIF) | Form for completion by the prescriber for each woman of non-childbearing potential prior to the initiation of their Thalidomide treatment. It is mandatory that women of non-childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
Lenalidomide | Adverse Event Form | Form to facilitate the reporting of adverse events in relation to this medicine to Accord | Download PDF |
Thalidomide | Adverse Event Form | Form to facilitate the reporting of adverse events in relation to this medicine to Accord | Download PDF |
Lenalidomide | Pregnancy Form | Form to facilitate the immediate reporting to Accord of any suspected, or confirmed, pregnancy whilst a patient is receiving this treatment | Download PDF |
Thalidomide | Pregnancy Form | Form to facilitate the immediate reporting to Accord of any suspected, or confirmed, pregnancy whilst a patient is receiving this treatment | Download PDF |
Lenalidomide | Pregnancy Outcome Form | Form to facilitate the report to Accord on the outcome of a pregnancy whilst a patient is receiving this treatment | Download PDF |
Thalidomide | Pregnancy Outcome Form | Form to facilitate the report to Accord on the outcome of a pregnancy whilst a patient is receiving this treatment | Download PDF |
Materials available for download and print:
Medicinal Name | Material | Description | Download |
---|---|---|---|
Lenalidomide | Information for Healthcare Professionals | Contains the information needed by healthcare professionals for prescribing and dispensing Accord Lenalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient | Download PDF |
Thalidomide | Information for Healthcare Professionals | Contains the information needed by healthcare professionals for prescribing and dispensing Accord Thalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient | Download PDF |
Lenalidomide | Treatment Checklist and Algorithm | Checklist to assist the healthcare professional with counselling a patient before they commence lenalidomide treatment to ensure it is used safely and correctly. The Algorithm provides high level steps for the process of pharmacy registration and the dispensing of lenalidomide | Download PDF |
Thalidomide | Treatment Checklist and Algorithm | Checklist to assist the healthcare professional with counselling a patient before they commence thalidomide treatment to ensure it is used safely and correctly. The Algorithm provides high level steps for the process of pharmacy registration and the dispensing of thalidomide | Download PDF |
Lenalidomide | Information for Patients | Information to be given to each patient receiving treatment to provide important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Lenalidomide along with how to report any side effects. | Download PDF |
Thalidomide | Information for Patients | Information to be given to each patient receiving treatment to provide important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Thalidomide along with how to report any side effects. | Download PDF |
Lenalidomide | Patient Information Card | Card to be given to each patient receiving treatment, as it provides important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Lenalidomide along with how to report any side effects. | Download PDF |
Thalidomide | Patient Information Card | Card to be given to each patient receiving treatment, as it provides important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Thalidomide along with how to report any side effects. | Download PDF |
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Accord-UK Ltd on 01271 385257 or email [email protected].
For UK Healthcare Professionals
Report Adverse Events
Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.
Adverse events should also be reported to Accord-UK Ltd:
Tel: 01271 385257
Email: [email protected]
For more information on lenalidomide or thalidomide from Accord, please click below .
Site intended for a UK audience only. UK-03777 April 2024